BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Pasithea Therapeutics Announces Results from 2023 Annual Meeting

  Pasithea Therapeutics Corp., announced that it held its annual meeting of stockholders on December 19, 2023.

  December 19, 2023

   · 

  4 min read
• Business

  InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs

  InxMed and Escugen announced that InxMed licensed EZWi-Fit® linker-payload platform from Escugen for the development of the next generation tumor-associated antigens targeting ADCs.

  December 19, 2023

   · 

  4 min read
• Business

  Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences

  Biocytogen Pharmaceuticals Co., Ltd. announced that it has entered into an antibody evaluation and option agreement with Neurocrine Biosciences, Inc.

  December 19, 2023

   · 

  2 min read
• Business

  Cenna Announces Appointment of David H. Crean to Board of Directors

  Cenna Biosciences announced the appointment of David H. Crean to the Cenna Board of Directors effective Dec. 12, 2023.

  December 19, 2023

   · 

  3 min read
• Burning Rock Announces Results of 2023 Annual General Meeting

  Burning Rock Biotech Limited announced that all shareholder resolutions proposed at the Company’s 2023 annual general meeting held today were duly passed.

  December 19, 2023

   · 

  2 min read
• Genetown

  bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock

  bluebird bio, Inc. announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price of $1.50 per share, before deducting underwriting discounts and commissions.

  December 19, 2023

   · 

  5 min read